May Hill Capital
GSK icon

May Hill Capital’s GSK GSK Stock Holding History

May Hill Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$446K Sell
9,269
-728
-7% -$37.2K 0.09% 141
2026
Q2 		$524K Buy
9,997
+53
+0.5% +$2.8K 0.11% 124
2026
Q1 		$549K Buy
9,944
+1,764
+22% +$95.6K 0.14% 101
2025
Q4 		$401K Buy
8,180
+256
+3% +$11.9K 0.11% 124
2025
Q3 		$342K Sell
7,924
-1,999
-20% -$78.1K 0.1% 132
2025
Q2 		$381K Buy
9,923
+514
+5% +$19.6K 0.13% 115
2025
Q1 		$365K Buy
+9,409
New +$344K 0.14% 109

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Equity Investment Corp
Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

May Hill Capital's GSK Position: Q3 2026 in Review

May Hill Capital reduced its GSK (GSK) stake by 7.3% in Q3 2026, selling an estimated $37.2K and leaving 9,269 shares worth $446K. The position accounts for 0.09% of the portfolio, ranked #141.

May Hill Capital first reported a position in GSK in Q1 2025 and has held it in 7 quarters since. The position peaked at $549K in Q1 2026. 654 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • May Hill Capital held 9,269 shares of GSK worth $446K as of Q3 2026.
  • May Hill Capital sold 728 GSK shares in Q3 2026, an estimated $37.2K.
  • GSK made up 0.09% of May Hill Capital's portfolio in Q3 2026, its #141 holding.
  • May Hill Capital first reported a position in GSK in Q1 2025 and has held it in 7 quarters since.
  • May Hill Capital's GSK position peaked at $549K in Q1 2026.
  • 654 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on May Hill Capital's 13F filing for Q3 2026, filed 3 Nov 2026.